- Home
- NBIX vs JHX Comparison
NBIX vs JHX Comparison
Compare NBIX & JHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- JHX
- Stock Information
- Founded
- NBIX 1992
- JHX 1888
- Country
- NBIX United States
- JHX Ireland
- Employees
- NBIX N/A
- JHX N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- JHX Building Materials
- Sector
- NBIX Health Care
- JHX Industrials
- Exchange
- NBIX Nasdaq
- JHX Nasdaq
- Market Cap
- NBIX 14.4B
- JHX 11.8B
- IPO Year
- NBIX 1996
- JHX N/A
- Fundamental
- Price
- NBIX $136.19
- JHX $21.62
- Analyst Decision
- NBIX Strong Buy
- JHX Strong Buy
- Analyst Count
- NBIX 17
- JHX 8
- Target Price
- NBIX $163.71
- JHX $27.25
- AVG Volume (30 Days)
- NBIX 895.4K
- JHX 7.1M
- Earning Date
- NBIX 10-29-2025
- JHX 11-18-2025
- Dividend Yield
- NBIX N/A
- JHX N/A
- EPS Growth
- NBIX 2.97
- JHX N/A
- EPS
- NBIX 3.39
- JHX 0.77
- Revenue
- NBIX $2,509,900,000.00
- JHX $3,785,500,000.00
- Revenue This Year
- NBIX $20.75
- JHX $16.52
- Revenue Next Year
- NBIX $14.73
- JHX $17.66
- P/E Ratio
- NBIX $40.40
- JHX $34.85
- Revenue Growth
- NBIX 18.42
- JHX N/A
- 52 Week Low
- NBIX $84.23
- JHX $17.85
- 52 Week High
- NBIX $154.61
- JHX $37.77
- Technical
- Relative Strength Index (RSI)
- NBIX 45.70
- JHX 60.08
- Support Level
- NBIX $135.59
- JHX $17.87
- Resistance Level
- NBIX $148.00
- JHX $18.89
- Average True Range (ATR)
- NBIX 3.15
- JHX 0.60
- MACD
- NBIX -1.16
- JHX 0.45
- Stochastic Oscillator
- NBIX 6.69
- JHX 78.25
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About JHX James Hardie Industries plc (Ireland)
James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings. Here, it is the largest manufacturer of fiber cement, which is mainly used for exterior siding on houses. Following the Azek acquisition in 2025, it also produces wooden composite decking materials, siding trims, and accessories for outdoor areas including stair and deck railing. Businesses in Australia, New Zealand, and Europe, make up the rest of earnings.